2-Mutant Inhibitors

Overview of attention for article published in Clinical Cancer Research, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

policy: 1 policy source
twitter: 5 X users

googleplus: 1 Google+ user
f1000: 1 research highlight platform

Readers on

mendeley: 84 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 11,985 followers.

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors https://t.co/NyOVtYuYdR https://t.co/kcbhSrUXwV

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors https://t.co/04SvdPvBsU

IDH1/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1/2-mutant inhibitors. https://t.co/NUWba2J7uk https://t.co/pstTeZbFjW

RT @ranjitbindra: Excited to see yet another lab reporting mutant IDH1/2-induced PARPi sensitivity, and reversal with mutIDH1/2 inhibitors.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.